PGR and cancer: The initial cancer was classified as early-stage (pT1c N0 M0), expressing estrogen and progesterone receptors (ER = 90%, PgR = 30%), a moderate proliferation index (Ki-67 = 30%), and a non-amplified c-ERB-2 gene.